Intuitive Surgical Inc

Intuitive Surgical develops surgical robots used by physicians to perform minimally invasive procedures — think laparoscopic surgery where a surgeon controls robotic arms through a console instead of making large incisions. Their flagship da Vinci system dominates the global surgical robotics market, and they also sell the Ion system for lung biopsies. Revenue comes from selling the multi-million-dollar systems, plus ongoing sales of single-use instruments, accessories, and service contracts.

Intuitive Surgical manufactures the da Vinci Surgical System, a robot-assisted platform enabling minimally invasive surgeries, and the Ion endoluminal system for lung biopsies [Yahoo Finance]. The company reported $10.1B in revenue (+20.5% YoY) with exceptional profitability (28.4% net margin) and a pristine balance sheet [Yahoo Finance]. Recent insider selling and a 53.8x P/E ratio warrant attention, though institutional holders remain largely stable [SEC Form 4] [EODHD].

Intuitive Surgical is financially excellent: growing fast, highly profitable, and completely debt-free.